RecruitingEarly Phase 1NCT04532346

Hydroxychloroquine in Children's Interstitial Lung Diseases With Genetic Causes

Studying Genetic interstitial lung disease

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Children's Hospital of Fudan University
Intervention: Hydroxychloroquine(drug)
Enrollment: 60 enrolled
Eligibility: 18 years · All sexes
Timeline: 2024 – 2027

Study locations (1)

Children's hospital of Fudan University, Shanghai, Shanghai Municipality, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04532346 on ClinicalTrials.gov

Other trials for Genetic interstitial lung disease

Additional recruiting or active studies for the same condition.

RECRUITINGNCT06702228
Precision Diagnosis and Care for Families With Pulmonary Fibrosis in Ireland
Royal College of Surgeons, Ireland

See all trials for Genetic interstitial lung disease →

← Back to all trials